Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt
Mark W. Russo, Paul F. Jacques, Matthew Mauro, Pat Odell, Robert S. Brown – 30 December 2003 – Transjugular intrahepatic portosystemic shunts (TIPSs) are used to treat variceal hemorrhage and refractory ascites. We sought to determine factors associated with stenosis and mortality after TIPS placement in patients with end‐stage liver disease. This is a retrospective review of 90 TIPSs placed over a 3‐year period. Demographic, clinical, and biochemical parameters were analyzed in univariate analyses to determine their association with stenosis and death.